nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A comparison of hyperthermia cisplatin sensitization in human ovarian carcinoma and glioma cell lines sensitive and resistant to cisplatin treatment
|
Raaphorst, G. P. |
|
1996 |
37 |
6 |
p. 574-580 |
artikel |
2 |
AG337, a novel lipophilic thymidylate synthase inhibitor: in vitro and in vivo preclinical studies
|
Webber, S. |
|
1996 |
37 |
6 |
p. 509-517 |
artikel |
3 |
A phase I and pharmacokinetic study of oral uracil, ftorafur, and leucovorin in patients with advanced cancer
|
Meropol, N. J. |
|
1996 |
37 |
6 |
p. 581-586 |
artikel |
4 |
A phase I/II study of high-dose cyclophosphamide, cisplatin, and thioTEPA followed by autologous bone marrow and granulocyte colony-stimulating factor-primed peripheral-blood progenitor cells in patients with advanced malignancies
|
Hussein, A. M. |
|
1996 |
37 |
6 |
p. 561-568 |
artikel |
5 |
A randomized trial comparing ftorafur alone with ftorafur plus tamoxifen in postoperative adjuvant therapy for breast cancerKinki Area Research Group for Postoperative Adjuvant Therapy for Breast Cancer
|
Sakai, K. |
|
1996 |
37 |
6 |
p. 587-592 |
artikel |
6 |
Carboplatin and vinorelbine in advanced non-small-cell lung cancer
|
Pronzato, P. |
|
1996 |
37 |
6 |
p. 610-612 |
artikel |
7 |
Intracellular localization and intercellular heterogeneity of the human DNA repair protein O6-methylguanine-DNA methyltransferase
|
Belanich, M. |
|
1996 |
37 |
6 |
p. 547-555 |
artikel |
8 |
In vitro schedule-dependent interaction between paclitaxel and cisplatin in human carcinoma cell lines
|
Kano, Y. |
|
1996 |
37 |
6 |
p. 525-530 |
artikel |
9 |
Is there a circadian variation in plasma concentrations of etoposide given by prolonged continuous infusion?
|
Ando, Yuichi |
|
1996 |
37 |
6 |
p. 616-618 |
artikel |
10 |
Lipid-complexed camptothecin: formulation and initial biodistribution and antitumor activity studies
|
Sugarman, S. M. |
|
1996 |
37 |
6 |
p. 531-538 |
artikel |
11 |
On the mechanism of action of doxorubicin encapsulation in nanospheres for the reversal of multidrug resistance
|
Hu, Yan-Ping |
|
1996 |
37 |
6 |
p. 556-560 |
artikel |
12 |
Penetration of intravesical doxorubicin in human bladders
|
Wientjes, M. G. |
|
1996 |
37 |
6 |
p. 539-546 |
artikel |
13 |
Peripheral blood mononuclear cell dihydropyrimidine dehydrogenase activity in volunteers with and without diabetes mellitus
|
Fleming, G. F. |
|
1996 |
37 |
6 |
p. 569-573 |
artikel |
14 |
Phase I study of ifosfamide plus high-dose epirubicin in advanced non-small-cell lung cancer
|
Gridelli, C. |
|
1996 |
37 |
6 |
p. 613-615 |
artikel |
15 |
Reversal of doxorubicin, etoposide, vinblastine, and taxol resistance in multidrug resistant human sarcoma cells by a polymer of spermine
|
Gosland, Michael P. |
|
1996 |
37 |
6 |
p. 593-600 |
artikel |
16 |
SarCNU (2-chloroethyl-3-sarcosinamide-1-nitrosourea): a novel analogue of chloroethylnitrosourea that is transported by the catecholamine uptake2 carrier, which mediates increased cytotoxicity
|
Panasci, L. C. |
|
1996 |
37 |
6 |
p. 505-508 |
artikel |
17 |
The integrity of cisplatin in aqueous and plasma ultrafiltrate media studied by 195Pt and 15N nuclear magnetic resonance
|
Brière, K. M. |
|
1996 |
37 |
6 |
p. 518-524 |
artikel |
18 |
Transforming growth factor-β in in vivo resistance
|
Teicher, B. A. |
|
1996 |
37 |
6 |
p. 601-609 |
artikel |